Funding Rounds
Xyall

Xyall Series B (2020, $5M)

Xyall

Platform specializing in molecular pathology solutions worldwide.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $5.55M

Raised Date: 2020-01-01